This cytokine is considered a master switch from tumor-promoting inflammation to antitumor immunity, thus dysregulation in IL-10 levels can importantly contribute to carcinogenesis and tumor progression (112, 165, 166). The gene discussed is IL10; the disease is neoplasm.